logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Stefan D. Anker

Deutsches Herzzentrum der Charite
H指数:162
被引数:14.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association of altered body composition with cardiac wasting in cancer with and without cardiotoxic therapy

改变的身体成分与接受和不接受心脏毒性治疗癌症患者中心脏消耗的关联

British Journal of Pharmacology
IF7.7
2026-10-070
OAAI
Sara Hadzibegovic; Jonathan L. Hella; Jan Porthun; Alessia Lena; Danara Krug; Iulia Baluta; Ursula Wilkenshoff; Amir A. Mahabadi; Matthias Totzeck; Tienush Rassaf; Stefan D. Anker; Wolfram Doehner; Ulrich Keller; Lars Bullinger; Dominik P. Modest; Barry J. A. Laird; Richard J. E. Skipworth; John G. F. Cleland; Christian Oeing; Stephan von Haehling; Ulf Landmesser; Markus S. Anker
Finerenone benefits in patients with cardio-kidney-metabolic syndrome with or without history of cancer: the FINE-HEART pooled analysis

在有无癌症病史的心肾代谢综合征患者中非奈利酮的获益：FINE-HEART合并分析

European Heart Journal
IF35.6
2026-08-180
OAAI
Mihály Ruppert; Muthiah Vaduganathan; Brian L Claggett; Akshay S Desai; Pardeep S Jhund; Alasdair Henderson; James Lay-Flurrie; Meike Brinker; Lucas Hofmeister; Markus S Anker; Carolyn S P Lam; Michele Senni; Sanjiv J Shah; Adriaan A Voors; Faiez Zannad; Peter Rossing; Luis M Ruilope; Bertram Pitt; Rajiv Agarwal; John J V McMurray; Scott D Solomon; Stefan D Anker; Gerasimos Filippatos
Target Versus Below-Target Dose ACE Inhibitors in U.S. Veterans with HFpEF: Differential Outcomes by CKD Status

目标剂量与低于目标剂量ACE抑制剂在美国射血分数保留的心力衰竭退伍军人中的使用：根据CKD状态区分结局

European Journal of Heart Failure
IF10.8
2026-07-300
PRE
Frederick Lu; Amiya A Ahmed; Sijian Zhang; Venkatesh K Raman; Samir S Patel; Jose D Vargas; Gregg C Fonarow; Paul A Heidenreich; John G F Cleland; Stefan D Anker; Michael Böhm; Marco Metra; Michael R Zile; Deepak L Bhatt; Tariq Ahmad; Phillip H Lam; Hans J Moore; Charles Faselis; Charity J Morgan; Helen M Sheriff; Qing Zeng-Treitler; Wen-Chih Wu; Ali Ahmed⁠
Outcomes With Finerenone by Baseline Treatment Goals in Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis

在2型糖尿病和慢性肾病中，根据基线治疗目标使用非奈利酮的结局：一项FIDELITY分析

diabetes, obesity and metabolism
IF0
2026-04-240
OAAI
João Sérgio Neves; Ana Rita Leite; Francisco Vasques-Nóvoa; Bertram Pitt; Gerasimos Filippatos; Luis M. Ruilope; Peter Rossing; Stefan D. Anker; Gianluigi Savarese; Charlie A. B. Scott; Andrea Lage; Meike D. Brinker; João Pedro Ferreira
Lifetime benefits of finerenone on cardiorenal morbidity and mortality in chronic kidney disease and type 2 diabetes: a pooled analysis of FIDELIO-DKD and FIGARO-DKD trials

慢性肾脏病和2型糖尿病中非奈利酮对心肾患病率和死亡率的全生命周期获益：FIDELIO-DKD和FIGARO-DKD试验的合并分析

European Heart Journal
IF35.6
2026-04-070
PRE
John W Ostrominski; Brendon L Neuen; Brian L Claggett; Rajiv Agarwal; Gerasimos Filippatos; Peter Rossing; Luis M Ruilope; Bertram Pitt; Meike Brinker; Andrea Lage; Patrick Schloemer; Katja Rohwedder; John J V McMurray; Scott D Solomon; Muthiah Vaduganathan; Stefan D Anker
Timing of Cardiovascular and Kidney Benefits with Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes

Finerenone在心力衰竭和伴有2型糖尿病的慢性肾脏病中心血管和肾脏获益的时间点

JACC
IF0
2025-11-180
OAAI
John W. Ostrominski; Brendon L. Neuen; Brian L. Claggett; Gerasimos Filippatos; Akshay S. Desai; Pardeep S. Jhund; Alasdair Henderson; Carolyn S.P. Lam; Michele Senni; Sanjiv J. Shah; Adriaan A. Voors; Faiez Zannad; Peter Rossing; Luis M. Ruilope; Stefan D. Anker; Bertram Pitt; Rajiv Agarwal; James Lay-Flurrie; Meike Brinker; Flaviana Amarante
Effects of SGLT2 inhibitors across the spectrum of albuminuria in cardiovascular–kidney–metabolic conditions: A pooled analysis of randomised trials

SGLT2抑制剂在心血管-肾脏-代谢疾病中不同白蛋白尿水平下的效果：一项随机试验的合并分析

Diabetes, Obesity and Metabolism
IF0
2025-11-100
OAAI
João Pedro Ferreira PhD; Pedro Marques MD; Stefan D. Anker PhD; Javed Butler MD; Gerasimos Filippatos PhD; Abhinav Sharma PhD; Francisco Vasques-Nóvoa MD; Luís Mendonça PhD; João Sérgio Neves PhD; Milton Packer MD; Faiez Zannad PhD
Comparing CKD populations with T1D and T2D: a perspective based on the FINE-ONE and FIDELITY populations

比较CKD、T1D和T2D人群：基于FINE-ONE和FIDELITY人群的视角

Nephrology Dialysis Transplantation
IF5.6
2025-10-010
OAAI
Heerspink, Hiddo J. L.; Agarwal, Rajiv; Amor, Antonio J.; Bech, Jesper N.; Cherney, David Z., I; Fiorina, Paolo; Rossing, Peter; Schousboe, Karoline; Selby, Nicholas M.; Anker, Stefan D.; Filippatos, Gerasimos; Pitt, Bertram; Ruilope, Luis M.; Lawatscheck, Robert; Brinker, Meike; Russell, Julie; Schloemer, Patrick; Mcgill, Janet B.
SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI

SGLT2抑制剂在心力衰竭的预防和治疗中的应用：HFA和HFAI的科学声明

ESC Heart Failure
IF3.7
2025-09-190
OAAI
Marco Metra; Daniela Tomasoni; Marianna Adamo; Offer Amir; Stefan D. Anker; Antoni Bayes-Genis; Michael Boehm; Javed Butler; Ovidiu Chioncel; Gerasimos Filippatos; Finn Gustafsson; Ewa A. Jankowska; Juan Carlos Kaski; Brenda Moura; Mark C. Petrie; Piotr Ponikowski; Amina Rakisheva; Arsen Ristic; Francois Roubille; Gianluigi Savarese; Petar Seferovic; Peter van der Meer; Maurizio Volterrani; Andrew J. Coats; Vijay K. Chopra; Giuseppe Rosano
Empagliflozin after myocardial infarction with or without diabetes and chronic kidney disease: Insights from EMPACT-MI

心力衰竭伴或不伴糖尿病和慢性肾脏病的患者接受心肌梗死后 empa gliflozin 治疗的疗效：来自 EMPACT-MI 的启示

ESC Heart Failure
IF3.7
2025-09-140
OAAI
Francesco Fioretti; Javed Butler; Jacob A. Udell; W. Schuyler Jones; Mark C. Petrie; Josephine Harrington; Michaela Mattheus; Johann Bauersachs; Antoni Bayes-Genis; Shaun G. Goodman; Tomasz Gasior; James L. Januzzi; Renato D. Lopes; Piotr Ponikowski; Xavier Rossello; Morten Schou; Peter van der Meer; Dragos Vinereanu; Shelley Zieroth; Martina Brueckmann; Mikhail Sumin; Deepak L. Bhatt; Adrian F. Hernandez; Stefan D. Anker
Heart failure therapy in patients with advanced cancer receiving specialized palliative care (EMPATICC trial)

请提供需要翻译的英文句子。

European Heart Journal
IF35.6
2025-08-300
OAAI
Markus S Anker; Amir A Mahabadi; Matthias Totzeck; Mitra Tewes; Muhammad Shahzeb Khan; Raluca I Mincu; Ulrike B Hendgen-Cotta; Lars Michel; Baicy Mathew; Ophelia Drescher; Martin Schuler; Ulrich Keller; Kathrin Rieger; Johann Ahn; Lars Bullinger; Dominik P Modest; Corinna Denecke; Lucie Kretzler; Luisa V Ramer; Danara Krug; Ulf Landmesser; Lorenz H Lehmann; Norbert Frey; Sven Bercker; Ulrich Laufs; Michael Böhm; Felix Mahfoud; Bela Merkely; Monika Diek; Javed Butler; Anja Veiser; Tim Heise; Martin Hellmich; Marius Placzek; Tim Friede; Stefan D Anker; Tienush Rassaf; null

研究方向

暂未获取到该数据
F
Filippatos, Gerasimos
H 指数:0论文数:20被引数:1,095
S
Stephan von Haehling
H 指数:98论文数:678被引数:4.2万
P
Piotr Ponikowski
H 指数:179论文数:1,444被引数:26.4万
A
Andrew J.S. Coats
H 指数:152论文数:1,155被引数:16.8万
W
Wolfram Doehner
H 指数:86论文数:490被引数:4.2万
J
Javed Butler
H 指数:127论文数:1,398被引数:11.9万
F
Faı̈ez Zannad
H 指数:148论文数:1,553被引数:16.6万
M
Marco Metra
H 指数:137论文数:1,798被引数:11.2万
M
Mitja Lainščak
H 指数:77论文数:491被引数:5.5万
E
Ewa A. Jankowska
H 指数:81论文数:701被引数:10.0万